Stock Analysis on Net
Stock Analysis on Net

Gilead Sciences Inc. (NASDAQ:GILD)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

Try for free

Gilead Sciences Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Gilead Sciences Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Accounts payable
Accrued rebates
Current portion of long-term debt, net
Other current liabilities
Current liabilities
Long-term debt, net, excluding current portion
Long-term income taxes payable
Deferred tax liability
Other long-term obligations
Long-term liabilities
Total liabilities
Preferred stock, par value $0.001 per share; none outstanding
Common stock, par value $0.001 per share
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Total Gilead stockholders’ equity
Noncontrolling interest
Total stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

The analysis of financial liabilities and equity items over the presented quarters reveals several notable trends and fluctuations.

Accounts Payable
This liability exhibited volatility with an initial decline from 590 million to 527 million by Q3 2020 before rising sharply to 905 million in Q4 2021. Subsequently, it showed a general downward trend, reaching a low of 537 million in Q1 2024, followed by a rebound to 833 million by Q2 2025.
Accrued Rebates
The accrued rebates remained relatively stable within a band roughly from 3200 to 4200 million. Peaks were observed at 4263 million in Q1 2024 and 4215 million in Q2 2025, indicating increased obligations related to rebates in recent quarters.
Current Portion of Long-Term Debt, Net
There was significant fluctuation, notably a spike to 4037 million in Q4 2021 from a low of 1021 million in Q2 2022. The amount declined again, then surged to 2806 million by mid-2025, suggesting periodic refinancing or restructuring of debt coming due in the short term.
Other Current Liabilities
This category showed general growth, climbing from 2833 million in Q1 2020 to peaks exceeding 5800 million in multiple quarters of 2021 and 2023. The data indicate increasing miscellaneous short-term obligations with some variability.
Current Liabilities
Current liabilities overall followed a pattern of early increase through 2020 to mid-2021, peaking above 13900 million in Q2 2023. A subsequent decline through 2024 brought these figures closer to 11000 million, but a moderate recovery is noted by Q2 2025.
Long-Term Debt, Net, Excluding Current Portion
This liability was comparatively stable but experienced a peak at 28645 million in Q4 2020, followed by a gradual descent to approximately 21500 million by late 2024. A modest rebound to over 22100 million occurred by mid-2025, indicating managed long-term debt levels with strategic adjustments.
Long-Term Income Taxes Payable
A clear downward trajectory is apparent, falling from around 5600 million in early 2020 to under 900 million by 2024 and 2025. This suggests reductions in deferred tax liabilities or settlements of tax obligations over time.
Deferred Tax Liability
Reported from late 2020 onwards, this liability declined steadily from nearly 3900 million to 652 million by mid-2025, reinforcing the trend of decreasing tax-related long-term obligations.
Other Long-Term Obligations
These obligations demonstrated relative stability, oscillating between roughly 900 and 1400 million without a marked trend, indicating steady other long-term commitments.
Long-Term Liabilities
Long-term liabilities peaked at almost 38800 million in Q1 2021 and displayed a steady decline thereafter to just under 25000 million by 2025, indicating significant amortization, repayment, or conversions influencing long-term financial structure.
Total Liabilities
Total liabilities increased sharply through 2020 and early 2021 reaching near 50000 million, then gradually decreased to roughly 36000 million in mid-2025. This reflects an overall deleveraging trend after temporary elevation in liabilities.
Common Stock
Remained constant at a nominal value, suggesting no new issuances or repurchases materially affecting common stock par value.
Additional Paid-in Capital
Exhibiting a consistent upward trend from 3311 million in early 2020 to over 8300 million by mid-2025, this indicates ongoing equity injections or stock-based compensation contributing to shareholder equity.
Accumulated Other Comprehensive Income (Loss)
This item fluctuated, crossing from positive to negative values episodically, indicating volatility in other comprehensive income components such as foreign currency translation adjustments or unrealized gains/losses on investments.
Retained Earnings
There was some volatility, with retained earnings falling sharply between late 2023 and early 2024 (down to 10656 million), then a mild recovery by mid-2025. The drop suggests periods of reduced profitability or dividend distributions impacting accumulated earnings.
Total Stockholders’ Equity
Total equity rose from about 22179 million in Q1 2020 to more than 22700 million by late 2023, followed by a notable decline to around 17400 million in early 2024. A recovery trend emerges in subsequent quarters, reaching near 19590 million by mid-2025. This reflects changes in retained earnings, additional paid-in capital, and comprehensive income effects.
Total Liabilities and Stockholders’ Equity
The aggregate of liabilities and equity followed a pattern of increase through 2020 and 2021, peaking above 68000 million, then decreasing steadily to about 55000-56000 million towards mid-2025, reflecting a contraction in total financing or asset base.

In summary, the financial data display a pattern of increased liabilities and equity capitalization through 2020 and early 2021, followed by a gradual reduction in liabilities and a partial contraction in equity levels during 2023 and early 2024. The movements in current liabilities and debt portions suggest active management of short-term financial obligations. The consistent rise in additional paid-in capital contrasts with the decrease in retained earnings and accumulated other comprehensive income volatility, indicating a complex equity dynamics possibly influenced by market conditions and operational performance.